Min Fang
Director/Board Member at JINXIN FERTILITY GROUP LIMITED
Net worth: 440 848 $ as of 2024-04-29
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Yiwen Zhu | M | 60 | 15 years | |
Meixi Deng | F | 51 |
Warburg Pincus Investment Consulting Co. Ltd.
Warburg Pincus Investment Consulting Co. Ltd. Investment ManagersFinance Part of Warburg Pincus & Company US LLC, Warburg Pincus Investment Consulting Co. Ltd. operates as a venture capital firm. The company is based in Shanghai, China.
HTDK Medical Holdings Ltd.
HTDK Medical Holdings Ltd. Financial ConglomeratesFinance HTDK Medical Holdings Ltd. operates as an investment holding company. It is principally engaged in providing product commercial solutions in medical device and consumer healthcare product sectors. The company specializes in medical device enterprises which cover the diagnosis, orthopedics, ophthalmology, cardiovascular and other indications. The company was founded on July 9, 2021 and is headquartered on Shanghai, China. | 8 years |
Wang Bin | M | 59 |
Sichuan Jinxin Fertility Medical Management Co., Ltd.
Sichuan Jinxin Fertility Medical Management Co., Ltd. Medical/Nursing ServicesHealth Services Sichuan Jinxin Fertility Medical Management Co., Ltd. operates fertility centers. The company was founded on September 12, 2016 and is headquartered in Chengdu, China. | - |
Yong Zhong | M | 52 |
Sichuan Jinxin Fertility Medical Management Co., Ltd.
Sichuan Jinxin Fertility Medical Management Co., Ltd. Medical/Nursing ServicesHealth Services Sichuan Jinxin Fertility Medical Management Co., Ltd. operates fertility centers. The company was founded on September 12, 2016 and is headquartered in Chengdu, China. | 6 years |
Chang Qing Ye | M | 53 | 5 years | |
Ying Zhong | M | 66 |
Sichuan Jinxin Fertility Medical Management Co., Ltd.
Sichuan Jinxin Fertility Medical Management Co., Ltd. Medical/Nursing ServicesHealth Services Sichuan Jinxin Fertility Medical Management Co., Ltd. operates fertility centers. The company was founded on September 12, 2016 and is headquartered in Chengdu, China. | 5 years |
Yi Jiang Zhuang | M | 60 |
HTDK Medical Holdings Ltd.
HTDK Medical Holdings Ltd. Financial ConglomeratesFinance HTDK Medical Holdings Ltd. operates as an investment holding company. It is principally engaged in providing product commercial solutions in medical device and consumer healthcare product sectors. The company specializes in medical device enterprises which cover the diagnosis, orthopedics, ophthalmology, cardiovascular and other indications. The company was founded on July 9, 2021 and is headquartered on Shanghai, China. | 5 years |
Yang Dong | M | 37 |
Sichuan Jinxin Fertility Medical Management Co., Ltd.
Sichuan Jinxin Fertility Medical Management Co., Ltd. Medical/Nursing ServicesHealth Services Sichuan Jinxin Fertility Medical Management Co., Ltd. operates fertility centers. The company was founded on September 12, 2016 and is headquartered in Chengdu, China. | 6 years |
Dai Feng | M | 48 |
China Biologic Products, Inc.
China Biologic Products, Inc. Pharmaceuticals: MajorHealth Technology China Biologic Products, Inc. operates as a biopharmaceutical company, which engages in the manufacture and distribution of plasma-based pharmaceutical products and other biological substances. Its products include human albumin, human immunoglobulin for intravenous injection, human Hepatitis B immunoglobulin, human rabies immunoglobulin, human immunoglobulin, human coagulation factor VIII, human prothrombin complex concentrate, and placenta polypeptide. The company was founded on December 20, 1989 and is headquartered in Beijing, China.
EA, Inc.
EA, Inc. Medical SpecialtiesHealth Technology EA, Inc. engages in the manufacturing and sale of orthodontic products. Its products include clear orthodontics retainers and aligners. The company was founded in June 2003 and is headquartered in Shanghai, China. | 3 years |
Danli Wang | M | 39 |
Warburg Pincus Investment Consulting Co. Ltd.
Warburg Pincus Investment Consulting Co. Ltd. Investment ManagersFinance Part of Warburg Pincus & Company US LLC, Warburg Pincus Investment Consulting Co. Ltd. operates as a venture capital firm. The company is based in Shanghai, China.
HTDK Medical Holdings Ltd.
HTDK Medical Holdings Ltd. Financial ConglomeratesFinance HTDK Medical Holdings Ltd. operates as an investment holding company. It is principally engaged in providing product commercial solutions in medical device and consumer healthcare product sectors. The company specializes in medical device enterprises which cover the diagnosis, orthopedics, ophthalmology, cardiovascular and other indications. The company was founded on July 9, 2021 and is headquartered on Shanghai, China.
Warburg Pincus Asia LLC (China Rep. Office)
| 4 years |
Aleksandrs Zhavoronkov | M | - |
InSilico Medicine Hong Kong Ltd.
InSilico Medicine Hong Kong Ltd. Information Technology ServicesTechnology Services InSilico Medicine Hong Kong Ltd. operates as bioinformatics company, which utilizes advances in genomics, big data analysis and deep learning for silico drug discovery and drug repurposing for aging and age-related diseases. The company was founded by Alex Zhavoronkov and is headquartered in Hong Kong. | - |
Ren Feng | M | - |
InSilico Medicine Hong Kong Ltd.
InSilico Medicine Hong Kong Ltd. Information Technology ServicesTechnology Services InSilico Medicine Hong Kong Ltd. operates as bioinformatics company, which utilizes advances in genomics, big data analysis and deep learning for silico drug discovery and drug repurposing for aging and age-related diseases. The company was founded by Alex Zhavoronkov and is headquartered in Hong Kong. | - |
Min Fang | M | 45 |
Stanford University
| 9 years |
Ai Ren | M | 39 | 9 years | |
Xiao Qing Yan | F | 54 | 6 years | |
Fang Jian | M | - |
Warburg Pincus Asia LLC (China Rep. Office)
| 1 years |
Lisa Liang | F | - |
Warburg Pincus Asia LLC (China Rep. Office)
| 5 years |
Hong Kun Liu | F | 36 |
Sichuan Jinxin Fertility Medical Management Co., Ltd.
Sichuan Jinxin Fertility Medical Management Co., Ltd. Medical/Nursing ServicesHealth Services Sichuan Jinxin Fertility Medical Management Co., Ltd. operates fertility centers. The company was founded on September 12, 2016 and is headquartered in Chengdu, China. | 3 years |
Viola Xin | F | - |
Warburg Pincus Asia LLC (China Rep. Office)
| - |
Yiwei Feng | M | - |
Warburg Pincus Asia LLC (China Rep. Office)
| - |
Yu Xie | F | 42 |
HTDK Medical Holdings Ltd.
HTDK Medical Holdings Ltd. Financial ConglomeratesFinance HTDK Medical Holdings Ltd. operates as an investment holding company. It is principally engaged in providing product commercial solutions in medical device and consumer healthcare product sectors. The company specializes in medical device enterprises which cover the diagnosis, orthopedics, ophthalmology, cardiovascular and other indications. The company was founded on July 9, 2021 and is headquartered on Shanghai, China. | 3 years |
Bingshi Tian | M | 48 |
HTDK Medical Holdings Ltd.
HTDK Medical Holdings Ltd. Financial ConglomeratesFinance HTDK Medical Holdings Ltd. operates as an investment holding company. It is principally engaged in providing product commercial solutions in medical device and consumer healthcare product sectors. The company specializes in medical device enterprises which cover the diagnosis, orthopedics, ophthalmology, cardiovascular and other indications. The company was founded on July 9, 2021 and is headquartered on Shanghai, China. | 3 years |
Yanqun Liu | M | 66 | 5 years | |
Rui Ping Dong | M | 62 |
Shanghai Haihe Biopharma Co., Ltd.
Shanghai Haihe Biopharma Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Haihe Biopharma Co., Ltd engages in the development, production, and sale of anti-tumor innovative drugs. It focuses on new anti-tumor drug projects, providing cancer therapies, and development of anti-tumor drugs such as oral paclitaxel, tyrosine kinase inhibitors, PI3Ka inhibitors, and Glumetinib. The company was founded on March 11, 2011 and is headquartered in Shanghai, China. | 6 years |
Hai Ying Liu | M | 48 |
Shanghai Haihe Biopharma Co., Ltd.
Shanghai Haihe Biopharma Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Haihe Biopharma Co., Ltd engages in the development, production, and sale of anti-tumor innovative drugs. It focuses on new anti-tumor drug projects, providing cancer therapies, and development of anti-tumor drugs such as oral paclitaxel, tyrosine kinase inhibitors, PI3Ka inhibitors, and Glumetinib. The company was founded on March 11, 2011 and is headquartered in Shanghai, China. | 7 years |
Zhi Gang Tian | M | 68 |
Shanghai Haihe Biopharma Co., Ltd.
Shanghai Haihe Biopharma Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Haihe Biopharma Co., Ltd engages in the development, production, and sale of anti-tumor innovative drugs. It focuses on new anti-tumor drug projects, providing cancer therapies, and development of anti-tumor drugs such as oral paclitaxel, tyrosine kinase inhibitors, PI3Ka inhibitors, and Glumetinib. The company was founded on March 11, 2011 and is headquartered in Shanghai, China. | 4 years |
Long Shi | M | 44 |
Beijing Warburg Pincus Investment Consulting Co. Ltd.
| 9 years |
Yang Yang Zhai | F | - | 5 years | |
Hsueh-Heui Chen | F | 53 |
HTDK Medical Holdings Ltd.
HTDK Medical Holdings Ltd. Financial ConglomeratesFinance HTDK Medical Holdings Ltd. operates as an investment holding company. It is principally engaged in providing product commercial solutions in medical device and consumer healthcare product sectors. The company specializes in medical device enterprises which cover the diagnosis, orthopedics, ophthalmology, cardiovascular and other indications. The company was founded on July 9, 2021 and is headquartered on Shanghai, China. | 3 years |
Xiaohua Yang | M | 48 |
HTDK Medical Holdings Ltd.
HTDK Medical Holdings Ltd. Financial ConglomeratesFinance HTDK Medical Holdings Ltd. operates as an investment holding company. It is principally engaged in providing product commercial solutions in medical device and consumer healthcare product sectors. The company specializes in medical device enterprises which cover the diagnosis, orthopedics, ophthalmology, cardiovascular and other indications. The company was founded on July 9, 2021 and is headquartered on Shanghai, China. | - |
Li Hong Geng | M | 55 | 4 years | |
Hanmei Huang | M | - | 4 years | |
Jun Yan | M | 42 |
Shanghai Haihe Biopharma Co., Ltd.
Shanghai Haihe Biopharma Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Haihe Biopharma Co., Ltd engages in the development, production, and sale of anti-tumor innovative drugs. It focuses on new anti-tumor drug projects, providing cancer therapies, and development of anti-tumor drugs such as oral paclitaxel, tyrosine kinase inhibitors, PI3Ka inhibitors, and Glumetinib. The company was founded on March 11, 2011 and is headquartered in Shanghai, China. | 4 years |
Jian Wei Li | M | 51 | 3 years | |
Andre Ren | M | - |
Warburg Pincus Asia LLC (China Rep. Office)
| - |
Qiang Zhao | M | 61 |
Shanghai Haihe Biopharma Co., Ltd.
Shanghai Haihe Biopharma Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Haihe Biopharma Co., Ltd engages in the development, production, and sale of anti-tumor innovative drugs. It focuses on new anti-tumor drug projects, providing cancer therapies, and development of anti-tumor drugs such as oral paclitaxel, tyrosine kinase inhibitors, PI3Ka inhibitors, and Glumetinib. The company was founded on March 11, 2011 and is headquartered in Shanghai, China. | 4 years |
Xiao Bo Wang | M | 49 | 5 years | |
Eric von Zwisler | M | - |
HTDK Medical Holdings Ltd.
HTDK Medical Holdings Ltd. Financial ConglomeratesFinance HTDK Medical Holdings Ltd. operates as an investment holding company. It is principally engaged in providing product commercial solutions in medical device and consumer healthcare product sectors. The company specializes in medical device enterprises which cover the diagnosis, orthopedics, ophthalmology, cardiovascular and other indications. The company was founded on July 9, 2021 and is headquartered on Shanghai, China. | - |
Rong Lyu | F | 43 | 3 years | |
Daniel Xiong | M | - |
Warburg Pincus Asia LLC (China Rep. Office)
| - |
Chris Shen | M | - |
Warburg Pincus Asia LLC (China Rep. Office)
| 9 years |
Alexander Wang | M | - |
Warburg Pincus Asia LLC (China Rep. Office)
| - |
Wei Cao | M | - |
Warburg Pincus Asia LLC (China Rep. Office)
| - |
Wenhan Jiang | M | - |
Warburg Pincus Asia LLC (China Rep. Office)
| - |
Frank M. Longo | M | - |
Stanford University
| 18 years |
David Yang | M | - |
Warburg Pincus Asia LLC (China Rep. Office)
| - |
Bob Lian | M | - |
Warburg Pincus Asia LLC (China Rep. Office)
| 5 years |
Brandon Li | M | - |
Warburg Pincus Asia LLC (China Rep. Office)
| 9 years |
Mathew Sun | M | - |
Warburg Pincus Asia LLC (China Rep. Office)
| 3 years |
Wanguang Zhang | M | 48 |
HTDK Medical Holdings Ltd.
HTDK Medical Holdings Ltd. Financial ConglomeratesFinance HTDK Medical Holdings Ltd. operates as an investment holding company. It is principally engaged in providing product commercial solutions in medical device and consumer healthcare product sectors. The company specializes in medical device enterprises which cover the diagnosis, orthopedics, ophthalmology, cardiovascular and other indications. The company was founded on July 9, 2021 and is headquartered on Shanghai, China. | - |
Sarah Li | F | - |
Warburg Pincus Asia LLC (China Rep. Office)
| - |
Kan Chen | M | 42 |
InSilico Medicine Hong Kong Ltd.
InSilico Medicine Hong Kong Ltd. Information Technology ServicesTechnology Services InSilico Medicine Hong Kong Ltd. operates as bioinformatics company, which utilizes advances in genomics, big data analysis and deep learning for silico drug discovery and drug repurposing for aging and age-related diseases. The company was founded by Alex Zhavoronkov and is headquartered in Hong Kong. | - |
Ying Luo | F | 53 |
Shanghai Haihe Biopharma Co., Ltd.
Shanghai Haihe Biopharma Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Haihe Biopharma Co., Ltd engages in the development, production, and sale of anti-tumor innovative drugs. It focuses on new anti-tumor drug projects, providing cancer therapies, and development of anti-tumor drugs such as oral paclitaxel, tyrosine kinase inhibitors, PI3Ka inhibitors, and Glumetinib. The company was founded on March 11, 2011 and is headquartered in Shanghai, China. | 4 years |
Zhi Jian Chen | M | 69 |
Shanghai Haihe Biopharma Co., Ltd.
Shanghai Haihe Biopharma Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Haihe Biopharma Co., Ltd engages in the development, production, and sale of anti-tumor innovative drugs. It focuses on new anti-tumor drug projects, providing cancer therapies, and development of anti-tumor drugs such as oral paclitaxel, tyrosine kinase inhibitors, PI3Ka inhibitors, and Glumetinib. The company was founded on March 11, 2011 and is headquartered in Shanghai, China. | 6 years |
Andrew Li | M | - |
Warburg Pincus Asia LLC (China Rep. Office)
| - |
Jian Ding | M | 71 |
Shanghai Haihe Biopharma Co., Ltd.
Shanghai Haihe Biopharma Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Haihe Biopharma Co., Ltd engages in the development, production, and sale of anti-tumor innovative drugs. It focuses on new anti-tumor drug projects, providing cancer therapies, and development of anti-tumor drugs such as oral paclitaxel, tyrosine kinase inhibitors, PI3Ka inhibitors, and Glumetinib. The company was founded on March 11, 2011 and is headquartered in Shanghai, China. | 13 years |
Qun Guo | F | 57 |
Shanghai Haihe Biopharma Co., Ltd.
Shanghai Haihe Biopharma Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Haihe Biopharma Co., Ltd engages in the development, production, and sale of anti-tumor innovative drugs. It focuses on new anti-tumor drug projects, providing cancer therapies, and development of anti-tumor drugs such as oral paclitaxel, tyrosine kinase inhibitors, PI3Ka inhibitors, and Glumetinib. The company was founded on March 11, 2011 and is headquartered in Shanghai, China. | 6 years |
Lin Xia | M | 42 |
Shanghai Haihe Biopharma Co., Ltd.
Shanghai Haihe Biopharma Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Haihe Biopharma Co., Ltd engages in the development, production, and sale of anti-tumor innovative drugs. It focuses on new anti-tumor drug projects, providing cancer therapies, and development of anti-tumor drugs such as oral paclitaxel, tyrosine kinase inhibitors, PI3Ka inhibitors, and Glumetinib. The company was founded on March 11, 2011 and is headquartered in Shanghai, China. | 7 years |
Steve Gao | M | - |
Warburg Pincus Asia LLC (China Rep. Office)
| - |
Qiqi Zhang | F | - |
Warburg Pincus Asia LLC (China Rep. Office)
| - |
Jericho Zhang | M | - |
Warburg Pincus Asia LLC (China Rep. Office)
| - |
Ling Chi | M | 69 | 6 years | |
Zach Zhang | M | - |
Warburg Pincus Asia LLC (China Rep. Office)
| - |
Lilian Zhu | F | - |
Warburg Pincus Asia LLC (China Rep. Office)
| - |
Qian Shi | M | - |
Warburg Pincus Asia LLC (China Rep. Office)
| - |
Zack Zheng | M | - |
Warburg Pincus Asia LLC (China Rep. Office)
| - |
Jackie Shao | M | - |
Warburg Pincus Asia LLC (China Rep. Office)
| - |
Jia Hou | F | 41 |
Shanghai Haihe Biopharma Co., Ltd.
Shanghai Haihe Biopharma Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Haihe Biopharma Co., Ltd engages in the development, production, and sale of anti-tumor innovative drugs. It focuses on new anti-tumor drug projects, providing cancer therapies, and development of anti-tumor drugs such as oral paclitaxel, tyrosine kinase inhibitors, PI3Ka inhibitors, and Glumetinib. The company was founded on March 11, 2011 and is headquartered in Shanghai, China. | 7 years |
Qingsong Zhu | M | - |
InSilico Medicine Hong Kong Ltd.
InSilico Medicine Hong Kong Ltd. Information Technology ServicesTechnology Services InSilico Medicine Hong Kong Ltd. operates as bioinformatics company, which utilizes advances in genomics, big data analysis and deep learning for silico drug discovery and drug repurposing for aging and age-related diseases. The company was founded by Alex Zhavoronkov and is headquartered in Hong Kong. | - |
Kwan Wai Leung | F | 43 |
HTDK Medical Holdings Ltd.
HTDK Medical Holdings Ltd. Financial ConglomeratesFinance HTDK Medical Holdings Ltd. operates as an investment holding company. It is principally engaged in providing product commercial solutions in medical device and consumer healthcare product sectors. The company specializes in medical device enterprises which cover the diagnosis, orthopedics, ophthalmology, cardiovascular and other indications. The company was founded on July 9, 2021 and is headquartered on Shanghai, China. | - |
Zhixing Chen | M | - |
Warburg Pincus Asia LLC (China Rep. Office)
| - |
Charles Li | M | - |
Warburg Pincus Asia LLC (China Rep. Office)
| - |
Roland Xu | M | - |
Warburg Pincus Asia LLC (China Rep. Office)
| - |
Richard Ge | M | - |
Warburg Pincus Asia LLC (China Rep. Office)
| - |
Hai Ying Zhu | F | 47 |
Shanghai Haihe Biopharma Co., Ltd.
Shanghai Haihe Biopharma Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Haihe Biopharma Co., Ltd engages in the development, production, and sale of anti-tumor innovative drugs. It focuses on new anti-tumor drug projects, providing cancer therapies, and development of anti-tumor drugs such as oral paclitaxel, tyrosine kinase inhibitors, PI3Ka inhibitors, and Glumetinib. The company was founded on March 11, 2011 and is headquartered in Shanghai, China. | 4 years |
Fred M. Gibbons | M | 75 |
Stanford University
| 18 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Hesaam Esfandyarpour | M | - |
Stanford University
| 5 years |
Styrmir Sigurjonsson | M | 50 |
Stanford University
| 7 years |
Helmy Eltoukhy | M | 45 |
Stanford University
| 9 years |
Andreas Eckner | M | - |
Stanford University
| 4 years |
Forrest White | M | - |
Stanford University
| 5 years |
Erin Yang | F | - |
Stanford University
| 5 years |
Nabeel Hasnain | M | - |
Stanford University
| 4 years |
Joseph Lau | M | - |
Stanford University
| - |
Ben Daniel | M | - |
Stanford University
| 1 years |
Joel Dudley | M | - |
Stanford University
| 4 years |
Geoffrey Woo | M | - |
Stanford University
| 4 years |
Iveshu Bhatia | M | - |
Stanford University
| 1 years |
Charles H. House | M | 83 |
Stanford University
| - |
Manu Kumar | M | - |
Stanford University
| 5 years |
Zavain Dar | M | 35 |
Stanford University
| 6 years |
Dmitry Pushkarev | M | - |
Stanford University
| 5 years |
Satyan Gajwani | M | 39 |
Stanford University
| 4 years |
Kunal Ghosh | M | - |
Stanford University
| 5 years |
Jason Min | M | - |
Stanford University
| 6 years |
Steve Abraham | M | - |
Stanford University
| 5 years |
Alex W. Bergman | M | - |
Stanford University
| 2 years |
Mike Rothenberg | M | - |
Stanford University
| 5 years |
Andrew Gustin | M | - |
Stanford University
| 9 years |
Guillaume Horel | M | - |
Stanford University
| 4 years |
Statistics
Country | Connections | % of total |
---|---|---|
China | 70 | 70.00% |
United States | 27 | 27.00% |
Hong Kong | 4 | 4.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Min Fang
- Personal Network